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Expression Cloning and Chromosomal Mapping of the 
Leukocyte Activation Antigen CD97, a New Seven-Span 
Transmembrane Molecule of the Secretin Receptor 
Superfamily with an Unusual Extracellular Domain
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CD97 is a monomeric glycoprotein of 75 to 85 kDa that is induced rapidly on the surface of most leukocytes upon 
activation. We herein report the isolation of a cDNA encoding human CD97 by expression cloning in COS cells, 
The 3-kb cDNA clone encodes a mature polypeptide chain of 722 amino acids with a predicted molecular mass 
of 79 kDa. Within the C-terminal part of the protein, a region with seven hydrophobic segments was identified, 
suggesting that CD97 is a seven-span transmembrane molecule. Sequence comparison indicates that CD97 is the 
first leukocyte Ag in a recently described superfamily that includes the receptors for secretin, calcitonin, and other 
mammalian and insect peptide hormones. Different from these receptors, CD97 has an extended extracellular 
region of 433 amino acids that possesses three N-terminal epidermal growth factor-like domains, two of them with 
a calcium-binding site, and a single Arg-Gly-Asp (RGD) motif. The existence of structural elements characteristic 
for extracellular matrix proteins in a seven-span transmembrane molecule makes CD97 a receptor potentially 
involved in both adhesion and signaling processes early after leukocyte activation. The gene encoding CD97 is 
localized on chromosome 19 (19pl 3.12—13.2). The Journal o f Immunology, 1995, 155: 1942-1950.
L eukocyte activation evokes coordinated changes 
in the expression of specific membrane molecules 
that allow cells to respond to environmental stim­
uli in an appropriate manner. Membrane receptors are in­
volved in distinct processes such as adhesion, migration, 
proliferation, differentiation, and effector functions (1, 2). 
Expression levels of these surface molecules are regulated 
via’ several mechanisms. First, lymphocyte activation is
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accompanied by the transcriptional activation of several 
genes (3). One of the earliest induced genes encoding 
membrane molecules is the CD69 gene, which encodes a 
type II integral membrane protein with a C-type lectin do­
main (4, 5). CD69 mRNA can be detected already within 
1 h after lymphocyte stimulation, whereas CD69 protein 
can be demonstrated at the cell surface within 2 to 4 h. 
Second, cellular activation initiates post-translational pro­
tein modifications that affect distribution and/or conforma­
tion of surface receptors. In this respect, mechanisms have 
been documented, such as fusion of intracellular gran­
ules with the cell membrane and the induction of neo­
epitopes on receptors that are already expressed on rest­
ing cells (6 - 8).
Recently, we have described a new activation Ag that 
was clustered during the Fifth International Workshop on 
Leukocyte Differentiation Antigens as CD97 (9, 10). Four 
mAbs, BL-Ac/F2, VIM3, VIM3B, and VIM3C, defined
Copyright © 1995 by The American Association of Immunologists 0022-1 767/95/$02,00
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CD97 as a single-chain glycoprotein of 75 to 85 kDa. 
Whereas granulocytes and monocytes cons tit utively ex- 
press CD97, resting lymphocytes bear the Ag only at low 
density. Cellular activation up-regulates surface expres­
sion of CD97 on B and T cells within 1 to 4 h. Markedly, 
these rapid kinetics even exceed those of the early activa­
tion Ag CD69. To begin to understand the function of 
CD97, we have isolated a cDNA encoding human CD97 
by expression cloning. We describe herein the molecular 
structure of the Ag and discuss its possible function. Fur­
thermore, the chromosomal localization of the CD97 gene 
is shown.
*
Materials and Methods
cDNA cloning and sequencing of CD97
The cDNA coding for human CD97 was isolated by expression cloning 
(IX, 12), as previously described (4). In brief, a cDNA library from hu­
man PBMC, stimulated for 6 h with PMA, was transfected into COS cells 
by the DEAE-dextran method. Cells expressing CD97 were separated by 
immunomagnetic selection with the mAb BL-Ac/F2 (9). Plasmid DNA 
was extracted from the sorted cells and used to transfect fresh COS cells 
by spheroplast fusion, followed by immunomagnetic selection and plas­
mid recover. After one additional round of screening, plasmid DNA pre­
pared from single bacterial colonies was transfected individually into 
COS cells and analyzed for expression of CD97 by immunoperoxidase 
staining.
An isolated cDNA clone missing a large part o f the 3 ' sequence was 
used to screen the enriched cDNA library (13). Therefore, plasmid DNA 
from COS cells that had been processed through one round of screening 
was transformed into Escherichia coll BA85 nitrocellulose filters (Schlei­
cher & Schuell, Inc., Dassel, Germany) were lifted from 2000 colonies and 
hybridized with the 32P-labeled incomplete clone for 20 h at 58^0 in a buffer 
consisting of 6X SSC, 5X Denhardt’s solution, 0,1% SDS, 10 mM EDTA, 
and 0.1 mg/ml herring sperm DNA. The filters were washed with 2X SSC/
0.1% SDS at 50°C and exposed to autoradiography.
Sequencing was performed on both strands with the fmol DNA-se- 
quencing system (Promega Corp., Madison» WI) and a series of 2 1 -mer 
synthetic oligonucleotide primers. CD97 sequence analysis and multiple 
alignment of the predicted amino acid sequence with the CLUSTAL 
program were performed in PC Gene (IntelliGenetics, Inc., Mountain 
View, CA).
Immunoprecipitation and in vitro translation
COS cells were transfected by the DEAE-dextran method with pCDM8 
vector containing either CD97 cDNA or no insert, After 3 days, the 
transfected cells, as well as PBMC that had been stimulated with 1 fig/ml 
PHA overnight, were labeled with 125I by the glucose oxidase/lactoper- 
oxidase protocol. Labeled cells were lysed in buffer containing 10 mM 
triethanolamine-HCl, pH 7.8,150 mM NaCl, 5 mM EDTA, 1 mM PMSF, 
20 jLtg/ml ovomucoid trypsin inhibitor, 1 mM Na-p-tosyl-L-lysine chlo- 
romethyl ketone, and 20 jug/ml leupeptin, supplemented with 1% Non- 
idet P-40. After centrifugation, supernatants were precleared with CNBr- 
activated Sepharose 4B and protein A-Sepharose (Pharmacia, Uppsala, 
Sweden) coated with normal mouse Ig, and incubated with the CD97 
mAbs BL-Ac/F2, VIM3, VIM3B, and VIM3C (from the Fifth Interna­
tional Workshop on Leukocyte Differentiation Antigens (10)) at 4°C 
for 1 h. Immune complexes were adsorbed onto protein A-Sepharose, 
washed intensively, eluted under reducing conditions, electrophoretically 
separated by 5 to 15% SDS-PAGE, and visualized by autoradiography. 
Hydrolysis of AMinked oligosaccharides from the precipitated protein 
was performed with Af-glycanase (Genzyme Corp., Boston, MA).
Expression of CD97 in vitro was performed by coupled transcription 
and translation in the TNT reticulocyte lysate system (Promega Corp.). 
The samples were separated by 5 to 15% SDS-PAGE and visualized by 
autoradiography.
RNA blot analysis
Total RNA was prepared from human PBMC, either untreated or stim­
ulated with 1 /xg/ml PHA at 1, 3, 8, and 24 h before isolation, with 
RNAzoI (Cinna/Biotecx, Friendswood, TX). For each sample, 10 )jlg 
RNA was separated electrophoretically on a 1.2% agarose/formaldehyde 
gel, transferred to a GeneScreen Plus nylon membrane (DuPont, Boston, 
MA), UV cross-linked, and prehybridized with 1,5X SSPE, 1% SDS,
0.5% nonfat dry milk, 0.5 mg/ml herring sperm DNA, and 10% dextran 
sulfate. Hybridization was performed in the same buffer with 32P-labeled 
CD97 cDNA insert at 60°C for 20 h. Before autoradiography, the blot 
was washed with 0.5X SSC/0.1% SDS at 50° C. Densitometry was per­
formed after exposure of the blot on a Phosphor Imager BAS 2000 (Fuji, 
Tokyo, Japan). In parallel, surface expression of CD97 was analyzed at 
the indicated time points with biotinylated mAb BL-Ac/F2 (9) and 
strep tavidin-phycoerythrin on a FACScan (Becton Dickinson, Mountain 
View, CA).
Chromosomal mapping o f the CD97 gene
The CD97 gene was localized by fluorescence in situ hybridization 
(FISH).3 Metaphase spreads from human PBL were denatured in 70% 
formamide at 70°C for 3 min, permeabilized with 100 /xg pepsin/ml 0,01 
M HC1 for 10 min at 37°C, and subsequently dehydrated in an ascending 
alcohol series. Chromosomes were hybridized with CD97 cDNA labeled 
by nick translation with biotin 14-dATP (Life Technologies, Inc,, Gaith­
ersburg, MD) at a concentration of 2 ng//xl in hybridization solution 
containing 60% formamide, 10% dextran sulfate, 2X SSC, 50 ng//xl her­
ring sperm DNA, and a 50-fold excess Cot-1 DNA. The probe was de­
natured at 95°C for 5 min and pre-annealed with Cot-1 DNA at 37°C for 
30 min. Hybridization was performed in 10 ^1 hybridization solution at 
37°C overnight, followed by posthybridization washes with 60% form­
amide at 42°C.
Demonstration of the probe was conducted by using a recently de­
scribed amplification method for in situ hybridization signals, on the 
basis of the deposition of biotinylated tyramine (14). All incubations 
were in PBS/0,05% Tween 20 containing 1% nonfat dry milk at 37°C for 
20 min. After pre-incubation, biotinylated CD97 cDNA was detected by 
using subsequently mouse anti-biotin Ig (1/1000; Dakopatts, Glostrup, 
Denmark), biotinylated horse anti-mouse Ig (1/200; Vector Laboratories, 
Burlingame, CA), avidin-biotin-horseradish peroxidase complex (1/100; 
Vector Laboratories), biotinylated tyramine/H2G2 (0.7 jxm/0.01% in 
PBS, 5 min), and fluorescein-labeled avidin ('1/1000 in 4X SSC; Vector 
Laboratories). The slides were counterstained with 4,6~diamino-2-phe-> 
nylindole (DAPI), and analyzed on a Leitz DMRB/E fluorescence mi­
croscope with filterblocks A (DAPI) and 13 (fluorescein). Kodak EPL 
400 films were used for photography. The map position of CD97 was 
determined by measuring the relative position of the probe on the chro­
mosome expressed as the fractional length of the whole chromosome 
relative to pter (FL-pter).
Results
Isolation and expression o f a cDNA encoding 
human CD97
Expression cloning in COS cells was used to isolate a 
cDNA encoding the human CD97 Ag. A  cDNA library 
from PMA-activated PBMC (4) was expressed transiently 
in COS cells, and after 3 days, cells expressing CD97 were 
enriched by immunomagnetic selection with the mAb BL- 
Ac/F2 (9), Plasmid DNA was extracted from the sorted 
cells, and the cycle of expression and immunomagnetic 
selection was repeated twice. The following analysis of
3 Abbreviations used in this paper: FISH, fluorescence in situ hybridization; 
ECF, epidermal growth factor; FL-pter, fractional length-pter; RGD, 
Arg-Gly-Asp.
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FIGURE 1. Expression of cDNA-encoded CD97 Ag. A, Im­
munoprécipitation of CD97 from PHA-activated PBMC and 
COS cells transfected with CD97 cDNA. Cells were surface- 
iodinated, and extracts were Immunoprecipitated by four dif­
ferent CD97 mAbs (BL-Ac/F2, VIM3, VIM3B, and VIM3C). 
The precipitates were analyzed by 5 to 15% SDS-PAGE. The 
positions of molecular size markers are shown on the /eft. B, 
Immunoprecipitated CD97 from transfected COS cells and 
PHA-activated PBMC was treated with N-glycanase before 
analysis by SDS-PAGE. Position of deglycosylation products 
is indicated by an arrowhead. C, In vitro translation of the 
CD97 cDNA. Samples were analyzed as above.
single clones by expression in COS cells and immunoper- 
oxidase staining identified one positive cDNA clone of 
573 bp. The identity of the isolated clone was proven by 
immunoprecipitation with the CD97 mAbs BL-Ac/F2, 
VIM3, VIM3B, and VIM3C. All four mAbs precipitated a 
protein of 30 kDa (data not shown). The difference of ap­
proximately 50 kDa to the known molecular mass of nat­
ural CD97 (9), as well as the sequence analysis, indicated 
that the isolated clone was incomplete, missing a large part 
of the 3' sequence.
We then used the incomplete clone as probe to screen
CD97 is a seven-span transmembrane glycoprotein 
related to the secretin receptor superfamily
The nucleotide sequence of the CD97 cDNA, with a length 
of 2921 bp, is shown in Figure 2. The first seven nucle­
otides have been supplemented from the 5' end of the 
incomplete 573-bp clone, whose sequence was found to be 
identical with the corresponding region of the 3-kb clone, 
The CD97 cDNA contains a single open reading frame of 
2226 bp encoding a polypeptide chain of 742 amino acids, 
The open reading frame is preceded by a 5' untranslated 
region of 70 bp and followed by a 3' untranslated'region 
of 625 bp, with a polyadenylation signal (ATTAAA) 13 bp 
upstream of the poly(A) tail. The N-terminal methionine is 
followed by a hydrophobic signal sequence. A possible 
cleavage site behind Thr20 (15) gives evidence that the 
mature polypeptide probably consists of 722 amino acids, 
with a predicted molecular mass of 79 kDa. However, in 
vitro translation of the cDNA revealed a product of ap­
proximately 63 kDa, corresponding in size with the non­
glycosylated CD97 that was immunoprecipitated from 
transfected COS cells (Fig. 1, B and C).
The discrepancy between the predicted molecular mass 
and the biochemical findings raises the question on the 
structure of the CD97 Ag. A hydropathy plot (16) identi­
fied seven hydrophobic segments within the C-terminal 
part of the molecule (Fig, 3A). This suggests that CD97 is 
a multispanning membrane protein, with an extended ex­
tracellular part of 433 amino acids, a 243-amino-acid re­
gion that passes the membrane seven times, and a cyto­
plasmic part of 46 amino acids (Fig. 3B). The tendency to 
migrate faster than predicted on the basis of m.w. is a well 
known feature of many multispanning molecules (17),
The seven-span transmembrane region shows no ho­
mology with the corresponding region from classical pro­
tein G-coupled receptors (18). However, a significant ho­
mology was found with the membrane-spanning region of 
members from the secretin receptor group (Fig. 4), This 
recently described superfamily includes peptide receptors
bacterial colonies from the cDNA library that had been with specificity for secretin (19), calcitonin (20), parathy- 
enriched by one cycle of expression and immunomagnetic r0^  hormone (21), vasoactive intestinal peptide (22),
selection in COS cells. A clone with an essentially larger 
insert of 3 kb was isolated. COS cells transfected with this
glucagon-like peptide 1 (23), growth hormone-releasing 
hormone (24), glucagon (25), pituitary adenylate cyclase- 
activating polypeptide (26), corticotropin-releasing factorclone stained positive with all CD97 mAbs. Immunopre­
cipitation of CD97 from COS cells transfected with the (27)> and insect diuretic hormone (28). The sequence iden- 
3-kb clone revealed an identical product with the four tity of 23 to 25% between CD97 and the receptors aligned 
CD97 mAbs (Fig. 1A). Surprisingly, with 63 kDa, this in Figure 4 is restricted largely to the seven-span trans­
protein was approximately 20 kDa smaller than the pre- membrane region and involves numerous hydrophilic 
cipitated CD97 Ag from activated PBMC. To investigate amino acid residues. Four highly conserved cysteines pre- 
whether incorrect N-glycosylation in COS cells gives rise ceding the first transmembrane domain of the related pro­
to the smaller molecular mass, the immunoprecipitates teins do not exist within the deduced amino acid sequence 
were treated with N-glycanase. As shown in Figure IB , a of CD97. Only the extracellular part of the diuretic hor- 
clear deglycosylation was found in precipitates from mone receptor from Acheta domesticus (GenBank acces- 
PBMC but not from COS cells, suggesting an incomplete sion number U15959) is weakly homologous with the cor-
cotranslational processing of CD97 in COS cells. responding region of CD97.
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CCAAAAGGACACTGTCrGTGAAGATATGACTTTCTCCACCTGGACCCCGCCCCCTGGAGTCCACAGCCAGACGCTTTCCCGATTCTTCGA 630
8H H M Ì i !  d m t f s t w t p p p g v h s q t l s r f f d  187
CAAAGTCCAGGACCTGGGCAGAGACTCCAAGACAAGCTCAGCCGAGGTCACCATCCAGAATGTCATCAAATTGGTGGATGAACTGATGGA 720
K V Q D L G R D S K T S S A E V T  I Q N V I  K t V D E L M E  217
AGCTCCTGGAGACGTAGAGGCCCTGGCGCCACCTGTCCGGCACCrCATAGCCACCCAGCTGCTCTCAAACCTTGAAGATATCATGAGGAT 810
A P G D V E A L A P P V R H L  I A T Q L L S N L E D  I M R I  247
CCTGGCCAAGAGCCTGCCTAAAGGCCCCTTCACCTACATTTCCCCTTCGAACACAGAGCTGACCCTGATGATCCAGGAGCGGGGGGACAA 900
L A K S L P K G P F T Y I S P S N T E L T L M  I Q E  l l i f i f l  K 277
GAACGTCACTATGGGTCAGAGCAGCGCACGCATGAAGCTGAATTGGGCTGTGGCAGCTGGAGCCGAGGATCCAGGCCCCGCCGTCGCGGG 990
I N~V T I  M G Q S S A R M K L N W A V A A G E D  P G P A V A G A  307
CATCCTCTCCATCCAGAACATGACGACATTGCTGGCCAATGCCTCCTTGAACCTGCATTCCAAGAAGCAAGCCGAACTGGAGGAGATATA 1080
I L S I Q I H M T I T L L A f  M A S 1 L N L H S K K Q A E L E E I Y  337
TGAAAGCAGCATCCGTGGTGTCCAACTCAGACGCCTCTCTGCCGTCAACTCCATCTTTCTGAGCCACAACAACACCAAGGAACTCAACTC 1170
E S S I R G V Q L R R L S A V N S I  F L S H  N N T K E L N S 367Ê
CCCCATCCTTTTCGCCTTCTCCCACCTTGAGTCCTCCGATGGGGAGGCGGGAAGAGACCCTCCTGCCAAGGACGTGATGCCTGGGCCACG 1260
P I L F A F S H L E S S D G E A G R D P P A K D V M P G P R  397
GCAGGAGCTGCTCTGTGCCTTCTGGAAGAGTGACAGCGACAGGGGAGGGCACTGGGCCACCGAGGTCTGCCAGGTGCTGGGCAGCAAGAA 1350
q e l l c a f w k s o s d r g g h w a t e v c q v l g s k Q ï  427
cggcagcacc a cc tg cc a a tg ca g cca cc tg a g ca g c ttta cg a tcc tta tg g c tca tta tg a cg tg g a g g a c tg g a a g c tg a ccc tg a t  1440
~ G S I T T C Q C S H t S S F T I t M A H Y D V E D W K  L T L I 457
CACCAGGGTGGGACTGGCGCTGTCACTCTTCTGCCTGCTGCTGTGCATCCTCACTTTCCTGCTGGTGCGGCCCATCCAGGGCTCGCGCAC 1530
T R V G L A L S L F C L L L C I  L T F L L V  R P I Q G S R T 487
CACCATACACCTGCACCTCTGCATCTGCCTCTTCGTGGGCTCCACCATCTTCCTGGCCGGCATCGAGAACGAAGGCGGCCAGGTGGGGCT 1620
T I H L H L C I C L F V G S T  I F L A G I  E N E G G Q V G L  517
GCGCTGCCGCCTGGTGGCCGGGCTGCTGCACTACrGTTTCCTGGCCGCCTTCTGCTGGATGAGCCTCGAAGGCCTGGAGCTCTACTTTCT 1710
R C R L V A G L  L H Y C F L A A F C W M S L E G L E L Y  F L 547
TGTGGTGCGCGTGTTCCAAGGCCAGGGCCTGAGiACGCGCTGGCTCTGCCTGATCGGCTATGGCGTGCCCCTGCTCATCGTGGGCGTCTC 1800
V V R V F Q G Q G L  S T R  W L C L I G Y G V P L L  I V G V S  577
GGCTGCCATCTACAGCAAGGGCTACGGCCGCCCCAGATACTGCTGGTTGGACTTTGAGCAGGGCTTCCTCTGGAGCTTCTTGGGACCTGT 1890
A A I Y S K G Y G R P R Y C W L D F E Q  G F L U S F L G P V  607
GACCTTCATCATTTTGTGCAATGCTGrCATTTTCGTGACTACCGTCTGGAAGCTCACTCAGAAGTTTTCTGAAATCAATCCAGACATGAA 1980
T F I  I L C M A V Ï  F V T T V W  K L T 0 K F S E 1 M P D M K  637
GAAATTAAAGAAGGCGAGGGCGCTGACCATCACGGCCATCGCGCAGCTCTTCCTGTTGGGCTGCACCTGGGTCTTTGGCCTGTTCATCTT 2070
< I  K < A R A t t i  T A I A O L F L L G C T W V F G L F I  F 667
CGACGATCGGAGCTTGGTGCTGACCTATGTGTTTACCATCCrCAACTGCCTGCAGGGCGCCTTCCTCTACCTGCTGCACTGCCTGCTCAA 2160
D D R S  L V L T Y V F T I  L N C L Q G A F L Y  L L H C L L  N 697
CAAGAAGGTTCGGGAAGAATACCGGAAGTGGGCCTGCCTAGTTGCTGGGGGGAGCAAGTACTCAGAATTCACCTCCACCACGTCTGGCAC 2250
K K V R E E Y R K W A C L V A G G S K Y S E  F T S T T S G T  727
TGGCCACAATCAGACCCGGGCCCTCAGGGCATCAGAGTCCGGCATATGAAGGCGCATGGTTCTGGACGGCCCAGCAGCTCCTGTGGCCAC 2340
G H N Q T R A L R A S E S G I 742
AGCAGCTTTGTACACGAAGACCATCCATCCTCCCTTCGTCCACCACTCTACTCCCTCCACCCTCCCTCCCTGATCCCGTGTGCCACCAGG 2430
AGGGAGTGGCAGCTATAGTCTGGCACCAAAGTCCAGGACACCCAGTGGGGTGGAGTCGGAGCCACTGGTCCTGCTGCTGGCTGCCTCTCT 2520
GCTCCACCTTGTGACCCAGGGTGGGGACAGGGGCTGGCCCAGGGCTGCAATGCAGCATGTTGCCCTGGCACCTGTGGCCAGTACTCGGGA 2610
CAGACTAAGGGCGCTTGTCCCATCCTGGACTTTTCCTCTCATGTCTTTGCTGCAGAACTGAAGAGACTAGGCGCTGGGGCTCAGCTTCCC 2700
TCTTAAGCTAAGACTGATGTCAGAGGCCCCATGGCGAGGCCCCTTGGGGCCACTGCCTGAGGCTCACGGTACAGAGGCCTGCCCTGCCTG 2790
GCCGGGCAGGAGGTTCTCACTGTTGTGAAGGTTGTAGACGTTGTGTAATGTGTTTTTATCTGTTAAAATTTTTCAGTGTTGACACTTAAA 2880
ATT AAAC AC AT GC AT A CAGAAA AAAAAAAAAAAA AAA AAAA 2921
FIGURE 2. Nucleotide sequence and deduced amino acici sequence of the CD97 cDNA. The signal sequence and the seven 
hydrophobic transmembrane segments are underlined. The polyadenylation signal is underlined twice, and potential N-glycosyla- 
tion sites are boxed. The three EGF~lfke domains and the RGD motif are shaded. The end of the incomplete 573-bp clone is marked 
with an arrow. The CD97 nucleotide sequence has been submitted to EMBL data base under accession number X84700,
During a large-scale random cDNA analysis on colon 
mucosa, an expressed sequence tag has recently been 
found (GenBank accession number D25916) that is iden­
tical with nucleotide 2412-2742 from the 3' noncoding 
region. This cDNA could possibly originate from m u­
cosa- localized lymphocytes.
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of the secretin receptor superfamily. By analyzing the de­
duced amino acid sequence, three N-terminal EGF-like 
domains were identified (Figs. 2 and 35). Remarkably, the 
sequence DXD/NECXnCXnCXNXnYXC is found in the 
second and third domain (Fig. 5). This consensus sequence 
indicates the existence of a calcium binding site (29-31) 
that is described for a subclass of EGF-like domains from 
different proteins (32). The consensus sequence contains 
two motifs. One, CXD/NXnY/FXC, is a recognition site 
for Asp/Asn j3-hydroxylase that post-translationally mod­
ifies the Asp/Asn behind the third cysteine by /3-hydroxy- 
lation. The other motif, DXD/NEXnD/Nhydroxy, is formed 
by amino acids, including the j3-hydroxylated Asp/Asn 
that bind the calcium ion.
A  search for established consensus sites within the ex­
tracellular region of CD97 revealed the existence of eight 
potential N-glycosylation sites, Asn-Xaa-Ser/Thr. This is 
in agreement with the reduction of the molecular mass of 
natural CD97 by approximately 15 to 20 kDa by N-gly- 
canase treatment (Fig. 35). Markedly, a single Arg-Gly- 
Asp (RGD) motif was found at amino acids 274-276. 
RGD motifs are known as potential recognition sequences 
for integrins (33). The C-terminal cytoplasmic part of 
CD97 is rather small (46 amino acids) and contains no 
potential phosphorylation sites.
Transcription of CD97 is up-regulated transiently 
during lymphocyte activation
To investigate transcription of the CD97 gene during lym- 
The extracellular region of CD97 is approximately 300 phocyte activation, RNA was analyzed from PBMC that 
amino acids longer than those from other known members had been stimulated with PHA for different periods of
433 aa extracellular region
243 aa seven-span 
transmambrane region
II III
RGD t
20 aa signal
pepiida
46 aa cytoplasmic 
region
FIGURE 3. /4, Hydropathy plot of the amino acid se­
quence, according to the method of Kyte and Doolittle (16). 
The hydrophobic transmembrane segments are indicated. B, 
Schematic representation of the molecule structure of CD97.
The extracellular part of CD97 contains three 
epidermal growth factor-like domains and a single 
Arg-Gly-Asp motif
hs CD 97 370
rn SecR 66
ss CalR 72
dm PTHR 101
ad DHR 61
hs CD97 463
rn SecR 151
ss CalR 158
dm PTHR 193
ad DHR 142
hs CD97 537
rn SecR 233
ss CalR 238
dm PTHR 293
ad DHR 217
hs CD97 623
rn SecR 318
ss CalR 322
dm PTHR 377
ad DHR 316
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FIGURE 4. Amino acid sequence alignment of CD97 with the receptors for secretin (rn SecR, rat) (19), calcitonin (ss CalR, 
pig) (20), parathyroid hormone (dm PTHR, opossum) (21), and diuretic hormone (ad DHR, cricket). Amino acids conserved 
between CD97 and other receptors are shaded. The asterisks indicate positions where amino acids are identical between all 
sequences.
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FIGURE 5. Sequence alignment of the three EGF-Sike do­
mains of CD97. The six conserved cysteines are shaded. As­
terisks indicate the consensus sequence for a calcium bind­
ing site DXD/NECXnCXnCXNXnYXC (29-31), which is 
found in the second and third domain. Residues that possibly 
bind the Ca2+ are underlined.
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time. Hybridization with a CD97 cDNA probe revealed an 
mRNA of approximately 3 kb, consistent in size with the 
CD97 cDNA clone (Fig. 6A). The transcription of the 
CD97 gene at the various time points was quantified by 
densitometry and compared with the expression of the pro­
tein on the cell surface (Fig. 6B). In line with the weak 
expression on resting cells, low levels of CD97 mRNA 
could be detected in nonactivated cells. After stimulation, 
CD97 mRNA showed a transient increase between 1 and 
8 h, with a maximum at 3 h. Thereafter, transcription de­
clined to basic levels within a few hours.
C D 97 is encoded  by.a gene on chromosome 19
Finally, the chromosomal localization of the CD97 gene 
was studied by FISH on human metaphase chromosomes 
by using biotinylated CD97 cDNA. The probe was hy­
bridized to chromosomal DNA and then visualized by a 
recently described amplification method for in situ hybrid­
ization signals, on the basis of the deposition of biotiny­
lated tyramine (17). As illustrated in Figure 7, clear hy­
bridization signals were detected on the short arm of 
chromosome 19. In most metaphases, both chromatids of 
two chromosomes were labeled. The map position of CD97 
was determined by length measurement of 10 chromosomes, 
with a 95% confidence interval. The mean FL-pter value of 
CD97 is 0.22 to 0.26, and corresponds to bands 19pl3.12~ 
13.2 (Fig. 8). The gene encoding the human glucagon recep­
tor, another member of the secretin receptor superfamily, has 
recently been assigned to chromosome 17 (34).
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FIGURE 6. Analysis of the transcription of the human 
CD97 gene. A, RNA blot analysis of PBMC stimulated with 1 
jLog/ml PHA at 1, 3, 8, and 24 h before RNA isolation. For 
each sample, 10 ^g were separated electrophoretically on a 
1.2% agarose/formaldehyde gel, transferred to a nyion mem­
brane, and hybridized with 32P-Iabeled CD97 cDNA. The 
positions of the ribosoma! RNA are indicated. B, Induction 
kinetics of CD97 mRNA and protein. Changes in CD97 mes­
sage were quantified by densitometry and normalized to the 
jS-actin control. Surface expression of CD97 on the activated 
cells was analyzed by flow cytometry.
Discussion
In this study, we describe the molecular structure of the 
human CD97 Ag. By expression cloning in COS cells (11, 
12), a cDNA was identified that encodes a mature protein 
of 722 amino acids. Near to the C-terminus, an extended 
hydrophobic region formed by seven distinct transmem­
brane segments was found that characterizes receptors 
coupled to G proteins (35). Structural analysis of new sev­
en-span transmembrane molecules has recently expanded 
the main group of these receptors with a superfamily des­
ignated after the first described secretin receptor (19). This 
superfamily involves proteins that bind biologic active 
peptide hormones as secretin, calcitonin, parathyroid hor­
mone, vasoactive intestinal peptide, glucagon-like peptide 
1, growth hormone-releasing hormone, glucagon, pituitary 
adenylate cyclase-activating polypeptide, corticotropin-re­
leasing factor, and insect diuretic hormone (19-28). Ho­
mology analysis indicates that CD97 is the first leukocyte 
Ag characterized that belongs to this group. However, se­
quence comparison with members from the secretin recep­
tor superfamily also revealed remarkable differences. The 
amino acid homology is restricted largely to the seven- 
transmembrane region, and is smaller than between the 
other proteins within the superfamily. Four highly con­
served cysteines preceding the first transmembrane do­
main, and probably important for the tertiary structure of
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FJGURE 8. Histogram of chromosome 19 with FL-pter of 
CD97 after FISH.
ing ability, as predicted from other members of the se­
cretin receptor superfamily that have been analyzed 
functionally so far. All of these receptors have been 
identified via their previously known peptide ligands 
FIGURE 7. A, Chromosomal localization of the CD97 that function as key regulators in a variety of endocri-
gene. Human metaphases were hybridized with biotinylated 
CD97 cDNA. Chromosomes 19 are indicated by arrow­
heads. B -D : Partial metaphases.
nologic, metabolic, and neurophysiologic processes. Li­
gand binding to the respective receptors leads to acti­
vation of adenylate cyclase and increase of intracellular 
cAMP most likely through coupling with G proteins 
(42). The regulation of physiologic processes through 
the extracellular ligand binding region, do not exist within biologic active peptide hormones necessarily depends 
the CD97 polypeptide chain. In contrast to all other mem- on the permanent presence of the respective receptor, 
bers of the secretin receptor superfamily, which have a The expression characteristics of CD97 (9) indicate that 
rather small extracellular region of approximately 150 only primed leukocytes are responsive to CD97-medi-
amino acids, that of CD97 extends 433 amino acids, 
Most surprising was the finding of structural similarities 
between the extracellular domain of CD97 and that from
ated signals. Potentially, binding of CD97 to its physi­
ologic ligand leads to a higher metabolic activity of 
activated leukocytes, thereby allowing the cells to re-
extracellular matrix proteins (36). Among those, the exis- spond in an appropriate manner to extracellular stimuli.
tence of EGF~like domains, with a calcium binding site in 
parallel with an RGD motif, has been described for nido- 
gen (37), fibrillin-1 and -2 (38, 39), and fibulin-2 (40).
As discussed, CD97 has a hybrid-like structure. 
Whereas the extracellular region contains elements that 
are in this combination known from extracellular matrix
EGF domains from many proteins are known to be in- proteins, the seven-transmembrane region places the 
volved in interactions with other proteins (32). In a sub- molecule within a superfamily of peptide receptors.
class of EGF-like domains, these interactions are stabi­
lized by Ca2+ bound to a conserved sequence (30-32). 
RGD motifs can serve as specific recognition sites for
Possibly, the extended extracellular region of CD97 
originates from additional exons taken up by an ances­
tor gene from the secretin receptor superfamily. This
members of the integrin family of adhesion molecules evolutionary process, during which proteins acquire a
(33). The interaction ofintegrins with various extracellular high structural variability by combining several differ-
matrix proteins, plasma proteins, and, as recently shown, ent domains and motifs, is known as exon shuffling (43),
also pathogenic ligands is based on RGD recognition (41). and has already been suggested for members of the
The structural findings therefore suggest an adhesive ca- main group of protein G-coupled receptors (44, 45).
pacity for the extracellular region of CD97. Furthermore, it seems likely that exon duplication gives
Interestingly, within the CD97 molecule, the assumed rise to the three EGF-like domains of CD97. Analyzing 
adhesive capacity is combined with a potential signal- the exon-intron structure of the coding gene could be
The Journal of  Immunology
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helpful in explaining the evolution of the CD97 Ag, and 
in evaluating functional similarities with other, struc­
turally related molecules.
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